Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit

被引:157
作者
Fish, Paul V. [1 ]
Filippakopoulos, Panagis [2 ]
Bish, Gerwyn [1 ]
Brennan, Paul E. [2 ]
Bunnage, Mark E. [1 ]
Cook, Andrew S. [1 ]
Federov, Oleg [2 ]
Gerstenberger, Brian S. [3 ]
Jones, Hannah
Knapp, Stefan [2 ]
Marsden, Brian [2 ]
Nocka, Karl
Owen, Dafydd R. [1 ]
Philpott, Martin [2 ]
Picaud, Sarah [2 ]
Primiano, Michael J.
Ralph, Michael J. [1 ]
Sciammetta, Nunzio [1 ]
Trzupek, John D.
机构
[1] Pfizer Worldwide R&D, Pfizer Worldwide Med Chem, Sandwich CT13 9NJ, Kent, England
[2] Univ Oxford, Struct Genom Consortium, Nuffield Dept Clin Med, Oxford OX3 7DQ, England
[3] Pfizer Worldwide R&D, Pfizer Worldwide Med Chem, Groton, CT 06340 USA
基金
英国惠康基金; 加拿大创新基金会;
关键词
CHROMATIN; DISCOVERY; ACETYLATION;
D O I
10.1021/jm3010515
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The posttranslational modification of chromatin through acetylation at selected histone lysine residues is governed by histone acetyltransferases (HATs) and histone deacetylases (HDACs). The Significance of this subset of the epigenetic code, is interrogated and interpreted by an acetyllysine-Specific protein-protein interaction with bromodomain reader modules. Selective inhibition of the brome and extra C-terminal domain (BET) family of bromodomains. with a., small molecule is feasible, and this may represent an opportunity for disease intervention through the recently disclosed antiproliferative and anti inflammatory properties of such inhibitors Herein, we describe the discovery and structure activity relationship (SAR) of a novel; small molecule chemical probe for BET family inhibition that was identified through the application of structure based fragment,assessment and optimization techniques This has yielded a potent, selective compound with cell based activity (PFI-1) that may further add to the understanding of BET family function within the bromodomains.
引用
收藏
页码:9831 / 9837
页数:7
相关论文
共 23 条
  • [1] Arrowsmith C. H., 2012, 4E96 RCSB PDB, DOI 10.2210/pdb4e96/pdb
  • [2] Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides
    Bamborough, Paul
    Diallo, Hawa
    Goodacre, Jonathan D.
    Gordon, Laurie
    Lewis, Antonia
    Seal, Jonathan T.
    Wilson, David M.
    Woodrow, Michael D.
    Chung, Chun-wa
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) : 587 - 596
  • [3] Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
    Choudhary, Chunaram
    Kumar, Chanchal
    Gnad, Florian
    Nielsen, Michael L.
    Rehman, Michael
    Walther, Tobias C.
    Olsen, Jesper V.
    Mann, Matthias
    [J]. SCIENCE, 2009, 325 (5942) : 834 - 840
  • [4] Chung C., 2012, DRUG DISCOV TODAY, V9, pe111, DOI DOI 10.1016/J.DDSTR.2011.12.002
  • [5] Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery
    Chung, Chun-wa
    Dean, Anthony W.
    Woolven, James M.
    Bamborough, Paul
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) : 576 - 586
  • [6] Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains
    Chung, Chun-wa
    Coste, Herve
    White, Julia H.
    Mirguet, Olivier
    Wilde, Jonathan
    Gosmini, Romain L.
    Delves, Chris
    Magny, Sylvie M.
    Woodward, Robert
    Hughes, Stephen A.
    Boursier, Eric V.
    Flynn, Helen
    Bouillot, Anne M.
    Bamborough, Paul
    Brusq, Jean-Marie G.
    Gellibert, Francoise J.
    Jones, Emma J.
    Riou, Alizon M.
    Homes, Paul
    Martin, Sandrine L.
    Uings, Iain J.
    Toum, Jerome
    Clement, Catherine A.
    Boullay, Anne-Benedicte
    Grimley, Rachel L.
    Blande, Florence M.
    Prinjha, Rab K.
    Lee, Kevin
    Kirilovsky, Jorge
    Nicodeme, Edwige
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (11) : 3827 - 3838
  • [7] Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
    Dawson, Mark A.
    Prinjha, Rab K.
    Dittmann, Antje
    Giotopoulos, George
    Bantscheff, Marcus
    Chan, Wai-In
    Robson, Samuel C.
    Chung, Chun-wa
    Hopf, Carsten
    Savitski, Mikhail M.
    Huthmacher, Carola
    Gudgin, Emma
    Lugo, Dave
    Beinke, Soren
    Chapman, Trevor D.
    Roberts, Emma J.
    Soden, Peter E.
    Auger, Kurt R.
    Mirguet, Olivier
    Doehner, Konstanze
    Delwel, Ruud
    Burnett, Alan K.
    Jeffrey, Phillip
    Drewes, Gerard
    Lee, Kevin
    Huntly, Brian J. P.
    Kouzarides, Tony
    [J]. NATURE, 2011, 478 (7370) : 529 - 533
  • [8] Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
    Filippakopoulos, Panagis
    Picaud, Sarah
    Mangos, Maria
    Keates, Tracy
    Lambert, Jean-Philippe
    Barsyte-Lovejoy, Dalia
    Felletar, Ildiko
    Volkmer, Rudolf
    Mueller, Susanne
    Pawson, Tony
    Gingras, Anne-Claude
    Arrowsmith, Cheryl H.
    Knapp, Stefan
    [J]. CELL, 2012, 149 (01) : 214 - 231
  • [9] Selective inhibition of BET bromodomains
    Filippakopoulos, Panagis
    Qi, Jun
    Picaud, Sarah
    Shen, Yao
    Smith, William B.
    Fedorov, Oleg
    Morse, Elizabeth M.
    Keates, Tracey
    Hickman, Tyler T.
    Felletar, Ildiko
    Philpott, Martin
    Munro, Shonagh
    McKeown, Michael R.
    Wang, Yuchuan
    Christie, Amanda L.
    West, Nathan
    Cameron, Michael J.
    Schwartz, Brian
    Heightman, Tom D.
    La Thangue, Nicholas
    French, Christopher A.
    Wiest, Olaf
    Kung, Andrew L.
    Knapp, Stefan
    Bradner, James E.
    [J]. NATURE, 2010, 468 (7327) : 1067 - 1073
  • [10] NUT midline carcinoma
    French, Christopher Alexander
    [J]. CANCER GENETICS AND CYTOGENETICS, 2010, 203 (01) : 16 - 20